Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 234

1.

European Union vaccine research--an overview.

Sautter J, Olesen OF, Bray J, Draghia-Akli R.

Vaccine. 2011 Sep 9;29(39):6723-7. doi: 10.1016/j.vaccine.2010.12.060. Epub 2010 Dec 31.

PMID:
21195799
2.

Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.

Gaspar R, Aksu B, Cuine A, Danhof M, Takac MJ, Linden HH, Link A, Muchitsch EM, Wilson CG, Ohrngren P, Dencker L.

Eur J Pharm Sci. 2012 Dec 18;47(5):979-87. doi: 10.1016/j.ejps.2012.09.020. Epub 2012 Oct 6.

PMID:
23046836
3.

The NCI All Ireland Cancer Conference.

Johnston PG, Daly PA, Liu E.

Oncologist. 1999;4(4):275-277.

4.

Science in Europe. The new framework for EU research and innovation.

Horvat M.

Science. 2011 Nov 25;334(6059):1066-8. doi: 10.1126/science.1214295. No abstract available.

PMID:
22116869
5.

Assembling a global vaccine development pipeline for infectious diseases in the developing world.

Serdobova I, Kieny MP.

Am J Public Health. 2006 Sep;96(9):1554-9. Epub 2006 Jul 27.

6.
7.

The innovative medicines initiative: a European response to the innovation challenge.

Goldman M.

Clin Pharmacol Ther. 2012 Mar;91(3):418-25. doi: 10.1038/clpt.2011.321. Epub 2012 Feb 8. Review.

PMID:
22318619
8.

Into the valley of death: research to innovation.

Hudson J, Khazragui HF.

Drug Discov Today. 2013 Jul;18(13-14):610-3. doi: 10.1016/j.drudis.2013.01.012. Epub 2013 Feb 9.

PMID:
23402848
10.

Human vaccine research in the European Union.

Olesen OF, Lonnroth A, Mulligan B.

Vaccine. 2009 Jan 29;27(5):640-5. doi: 10.1016/j.vaccine.2008.11.064. Epub 2008 Dec 6. Review.

PMID:
19059446
11.

Basic and clinical proteomics from the EU Health Research perspective.

Dyląg T, Jehenson P, van de Loo JW, Sanne JL.

Proteomics Clin Appl. 2010 Dec;4(12):888-91.

PMID:
21179890
12.

Novel human vaccine strategies and the 5th Framework Programme: pushing the envelope.

Tagliabue A, Cesaroni MP, Lewis DJ.

Vaccine. 2003 Jun 1;21 Suppl 2:S121-7.

PMID:
12763695
13.

European Vaccine Initiative: lessons from developing malaria vaccines.

Geels MJ, Imoukhuede EB, Imbault N, van Schooten H, McWade T, Troye-Blomberg M, Dobbelaer R, Craig AG, Leroy O.

Expert Rev Vaccines. 2011 Dec;10(12):1697-708. doi: 10.1586/erv.11.158. Review.

PMID:
22085173
14.

Tuberculosis research in the European union: past achievements and future challenges.

Lång H, Quaglio G, Olesen OF.

Tuberculosis (Edinb). 2010 Jan;90(1):1-6. doi: 10.1016/j.tube.2009.10.002. Epub 2009 Oct 31.

PMID:
19880350
15.

Regulatory structures for gene therapy medicinal products in the European Union.

Klug B, Celis P, Carr M, Reinhardt J.

Methods Enzymol. 2012;507:337-54. doi: 10.1016/B978-0-12-386509-0.00017-X.

PMID:
22365782
16.

Building a stronger foundation for a new century of treatments and cures.

Sebelius K.

Health Aff (Millwood). 2011 Jan;30(1):81-3. doi: 10.1377/hlthaff.2010.0995.

PMID:
21209442
17.

[ECRIN (European clinical research infrastructures network), a pan-European infrastructure for clinical research].

Demotes-Mainard J.

Bull Acad Natl Med. 2010 Dec;194(9):1683-94. Review. French.

PMID:
22043593
18.

Chinese villages and their sustainable future: the European Union-China-Research Project "SUCCESS".

Dumreicher H.

J Environ Manage. 2008 Apr;87(2):204-15. Epub 2007 Sep 20.

PMID:
17888563
19.

The U.S. vaccine and immunization enterprise: Working to sustain and foster vaccine innovation.

Shen AK.

Hum Vaccin. 2009 Oct;5(10):649-53. Epub 2009 Oct 7.

PMID:
19713758
20.

Funding cuts for public health projects in Europe may affect international cancer effort.

Illman J.

J Natl Cancer Inst. 2004 Mar 17;96(6):428-9. No abstract available.

PMID:
15026462

Supplemental Content

Support Center